Valuation: Celltrion, Inc.

Capitalization 40,514B 27.12B 23.13B 21.21B 20.08B 37.21B 2,596B 37.57B 253B 98.38B 1,231B 102B 99.61B 4,278B P/E ratio 2026 *
31.2x
P/E ratio 2027 * 26x
Enterprise value 42.43B 28.4M 24.22M 22.21M 21.03M 38.97M 2.72B 39.34M 265M 103M 1.29B 107M 104M 4.48B EV / Sales 2026 *
7.96x
EV / Sales 2027 * 6.79x
Free-Float
70.87%
Yield 2026 *
0.4%
Yield 2027 * 0.43%
1 day+1.05%
1 week-2.28%
Current month-3.59%
1 month-3.20%
3 months-18.95%
6 months+5.69%
Current year+6.80%
1 week 187,400
Extreme 187400
206,500
1 month 187,400
Extreme 187400
212,000
Current year 187,400
Extreme 187400
251,000
1 year 144,615.38
Extreme 144615.3846
251,000
3 years 119,963.37
Extreme 119963.37
251,000
5 years 119,963.37
Extreme 119963.37
259,410.96
10 years 65,004.08
Extreme 65004.0844
341,497.26
Manager TitleAgeSince
Chief Executive Officer 65 19/03/2015
Chief Executive Officer 42 25/03/2021
President 50 12/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 31/03/2005
Director/Board Member 66 -
Change 5d. change 1-year change 3-years change Capi.($)
+1.05%-2.28%+32.43%+26.70% 27.12B
-0.82%-4.11%-17.51%-19.01% 42.69B
+1.39%+5.91%+35.08%+32.18% 35.03B
+1.09%-1.01%+247.95%+463.28% 30.98B
+0.87%-0.77%+12.12%-6.97% 29.22B
-0.43%+5.49% - - 14.76B
-3.59%-3.37%+113.03%+4,035.93% 13.03B
+0.60%+0.77%+126.16%+113.55% 12.53B
-0.07%-1.33%+7.36%-2.15% 12.21B
+0.59%-2.46%+33.79%+100.89% 11.99B
Average -0.19%+0.21%+65.60%+527.15% 22.96B
Weighted average by Cap. -0.13%+0.24%+60.27%+327.67%

Financials

2026 *2027 *
Net sales 5,327B 3.57B 3.04B 2.79B 2.64B 4.89B 341B 4.94B 33.22B 12.94B 162B 13.38B 13.1B 562B 6,113B 4.09B 3.49B 3.2B 3.03B 5.61B 392B 5.67B 38.12B 14.85B 186B 15.35B 15.03B 645B
Net income 1,379B 923M 787M 722M 684M 1.27B 88.37B 1.28B 8.6B 3.35B 41.91B 3.46B 3.39B 146B 1,668B 1.12B 952M 873M 827M 1.53B 107B 1.55B 10.4B 4.05B 50.69B 4.19B 4.1B 176B
Net Debt 1,913B 1.28B 1.09B 1B 948M 1.76B 123B 1.77B 11.93B 4.65B 58.15B 4.81B 4.7B 202B 972B 651M 555M 509M 482M 893M 62.28B 901M 6.06B 2.36B 29.54B 2.44B 2.39B 103B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
12/05/26 193,300.00 +1.05% 1,168,312
11/05/26 191,300.00 -3.58% 864,117
08/05/26 198,400.00 -2.02% 620,707
07/05/26 202,500.00 +4.01% 1,074,408
06/05/26 194,700.00 -1.57% 934,691
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
193,300.00KRW
Average target price
262,956.52KRW
Spread / Average Target
+36.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock